glp-1 long term Weight maintenance after discontinuation of therapies GLP-1 Agonists: A Comprehensive Overview

Finally, a four-year, multicenter, clinical trial in 421 diabetic patients with distal symmetric sensorimotor polyneuropathy found no difference between oral administration of 600 mg/day of lipoic and placebo on the primary endpoint, a composite score that assessed neuropathic impairment of the lower limbs and nerve conduction (78)

Your doctor might know it by brand names like Ozempic, Wegovy, or Rybelsus

The search was filtered to include only randomized controlled trials (RCTs) or meta-analyses of human data

Risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists